SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut–pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

SCO-792 Reduces High-Fat Diet-Induced Chronic Pancreatitis by Influencing the Gut-Pancreas Interaction Through AMPK/ACC and TLR4/NF-κB Pathways

  • By

  • Yanru Kang

  • Ningning Sun

  • Weijie Yao

  • Jinyu Li

  • Hua Yin

  • Jiyue Wang

  • Zuozheng Wang

  • Shaoqi Yang

  • Xiaoli Yang

  • September 3, 2026

Share

Clinical Scorecard: SCO-792 Reduces High-Fat Diet-Induced Chronic Pancreatitis by Influencing the Gut-Pancreas Interaction Through AMPK/ACC and TLR4/NF-κB Pathways

At a Glance

CategoryDetail
ConditionChronic Pancreatitis (CP)
Key MechanismsGut-pancreas interaction, AMPK/ACC pathway, TLR4/NF-κB pathway
Target PopulationIndividuals with chronic pancreatitis aggravated by high-fat diet
Care SettingPreclinical research

Key Highlights

  • SCO-792 mitigated HFD-exacerbated pancreatic injury and fibrosis.
  • Maintained pancreatic lipid metabolic homeostasis via AMPK/ACC pathway.
  • Reconstituted gut microbiota composition and promoted SCFA production.
  • Limited serum LPS translocation and inhibited pancreatic inflammation.
  • Enhanced macrophage polarization toward the M2 phenotype.

Guideline-Based Recommendations

Diagnosis

  • Chronic pancreatitis is diagnosed based on clinical history, imaging, and biochemical tests.

Management

  • SCO-792 may serve as a therapeutic agent for managing chronic pancreatitis.

Monitoring & Follow-up

  • Monitor pancreatic function and gut microbiota composition in patients.

Risks

  • High-fat diets are linked to increased risk of chronic pancreatitis.

Patient & Prescribing Data

Patients with chronic pancreatitis and metabolic syndrome.

SCO-792 shows potential in modulating gut microbiota and reducing pancreatic inflammation.

Clinical Best Practices

  • Consider dietary modifications to reduce fat intake in chronic pancreatitis patients.
  • Evaluate the role of gut microbiota in the management of chronic pancreatitis.

Related Resources & Content

Original Source(s)

SCO‑792 alleviates HFD‑aggravated chronic pancreatitis by modulating the gut–pancreas axis via the AMPK/ACC and TLR4/NF‑κB signaling pathways

  • by Yanru Kang, Ningning Sun, Weijie Yao, Jinyu Li, Hua Yin, Jiyue Wang, Zuozheng Wang, Shaoqi Yang, Xiaoli Yang

  • September 3, 2026

Related Content

Short-term postoperative neurocognitive safety and recovery profiles of remimazolam tosilate combined with flumazenil vs. propofol in cirrhotic patients undergoing endoscopic variceal treatment: a randomized controlled trial

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min
Correction: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection